Caribou Biosciences, Inc.
CRBU
$0.7331
-$0.046-5.90%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.62% | -41.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.62% | -41.57% | |||
| Cost of Revenue | 0.14% | -15.95% | |||
| Gross Profit | 0.04% | 13.18% | |||
| SG&A Expenses | 76.54% | -48.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.83% | -23.85% | |||
| Operating Income | -13.45% | 22.44% | |||
| Income Before Tax | -2.35% | 7.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.32% | 7.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.32% | 7.99% | |||
| EBIT | -13.45% | 22.44% | |||
| EBITDA | -13.91% | 23.65% | |||
| EPS Basic | -1.54% | 8.12% | |||
| Normalized Basic EPS | -15.16% | 19.84% | |||
| EPS Diluted | -1.54% | 8.12% | |||
| Normalized Diluted EPS | -15.16% | 19.84% | |||
| Average Basic Shares Outstanding | 0.78% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.78% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||